<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39451653</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4418</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>20</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>19</Day></PubDate></JournalIssue><Title>Diagnostics (Basel, Switzerland)</Title><ISOAbbreviation>Diagnostics (Basel)</ISOAbbreviation></Journal><ArticleTitle>Investigation of Long-Term CD4+ T Cell Receptor Repertoire Changes Following SARS-CoV-2 Infection in Patients with Different Severities of Disease.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2330</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/diagnostics14202330</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The difference in the immune response to severe acute respiratory syndrome coro-navirus 2 (SARS-CoV-2) in patients with mild versus severe disease remains poorly understood. Recent scientific advances have recognised the vital role of both B cells and T cells; however, many questions remain unanswered, particularly for T cell responses. T cells are essential for helping the generation of SARS-CoV-2 antibody responses but have also been recognised in their own right as a major factor influencing COVID-19 disease outcomes. The examination of T cell receptor (TCR) family differences over a 12-month period in patients with varying COVID-19 disease severity is crucial for understanding T cell responses to SARS-CoV-2.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We applied a machine learning approach to analyse TCR vb family responses in COVID-19 patients (<i>n</i> = 151) across multiple timepoints and disease severities alongside SARS-CoV-2 infection-naïve (healthy control) individ-uals (<i>n</i> = 62).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Blood samples from hospital in-patients with moderate, severe, or critical disease could be classified with an accuracy of 94%. Furthermore, we identified significant variances in TCR vb family specificities between disease and control subgroups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings suggest advantageous and disadvantageous TCR repertoire patterns in relation to disease severity. Following validation in larger cohorts, our methodology may be useful in detecting protective immunity and the assessment of long-term outcomes, particularly as we begin to unravel the immunological mechanisms leading to post-COVID complications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Callery</LastName><ForeName>Emma L</ForeName><Initials>EL</Initials><Identifier Source="ORCID">0000-0003-0786-9182</Identifier><AffiliationInfo><Affiliation>Department of Immunology, Lancashire Teaching Hospitals NHS Foundation, Preston PR2 9HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morais</LastName><ForeName>Camilo L M</ForeName><Initials>CLM</Initials><Identifier Source="ORCID">0000-0003-2573-787X</Identifier><AffiliationInfo><Affiliation>Institute of Chemistry, Federal University of Rio Grande do Norte, Natal 59072-970, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Jemma V</ForeName><Initials>JV</Initials><Identifier Source="ORCID">0000-0001-5106-2875</Identifier><AffiliationInfo><Affiliation>Department of Immunology, Lancashire Teaching Hospitals NHS Foundation, Preston PR2 9HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Challen</LastName><ForeName>Kirsty</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Lancashire Teaching Hospitals NHS Foundation, Preston PR2 9HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowbottom</LastName><ForeName>Anthony W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Department of Immunology, Lancashire Teaching Hospitals NHS Foundation, Preston PR2 9HT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Central Lancashire, Preston PR1 2HE, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Diagnostics (Basel)</MedlineTA><NlmUniqueID>101658402</NlmUniqueID><ISSNLinking>2075-4418</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">T cell receptor</Keyword><Keyword MajorTopicYN="N">TCR repertoire</Keyword><Keyword MajorTopicYN="N">flow cytometry</Keyword><Keyword MajorTopicYN="N">immune response</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">severity model</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>9</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39451653</ArticleId><ArticleId IdType="pmc">PMC11507081</ArticleId><ArticleId IdType="doi">10.3390/diagnostics14202330</ArticleId><ArticleId IdType="pii">diagnostics14202330</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72,314 Cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Driscoll M., Ribeiro Dos Santos G., Wang L., Cummings D.A.T., Azman A.S., Paireau J., Fontanet A., Cauchemez S., Salje H. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021;590:140–145. doi: 10.1038/s41586-020-2918-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2918-0</ArticleId><ArticleId IdType="pubmed">33137809</ArticleId></ArticleIdList></Reference><Reference><Citation>Zornikova K.V., Sheetikov S.A., Rusinov A.Y., Iskhakov R.N., Bogolyubova A.V. Architecture of the SARS-CoV-2-specific T cell repertoire. Front. Immunol. 2023;14:1070077. doi: 10.3389/fimmu.2023.1070077.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1070077</ArticleId><ArticleId IdType="pmc">PMC10067759</ArticleId><ArticleId IdType="pubmed">37020560</ArticleId></ArticleIdList></Reference><Reference><Citation>Fineberg H.V., Brown L., Worku T., Goldowitz I., editors. A Long COVID Definition: A Chronic, Systemic Disease State with Profound Consequences. National Academies Press; Washington, DC, USA: 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">39110819</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133–146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Liew F., Efstathiou C., Fontanella S., Richardson M., Saunders R., Swieboda D., Sidhu J.K., Ascough S., Moore S.C., Mohamed N., et al. Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease. Nat. Immunol. 2024;25:607–621. doi: 10.1038/s41590-024-01778-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-024-01778-0</ArticleId><ArticleId IdType="pmc">PMC11003868</ArticleId><ArticleId IdType="pubmed">38589621</ArticleId></ArticleIdList></Reference><Reference><Citation>Vecchio E., Rotundo S., Veneziano C., Abatino A., Aversa I., Gallo R., Giordano C., Serapide F., Fusco P., Viglietto G., et al. The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection. J. Transl. Med. 2024;22:33. doi: 10.1186/s12967-024-04852-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-024-04852-1</ArticleId><ArticleId IdType="pmc">PMC10771664</ArticleId><ArticleId IdType="pubmed">38185632</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Li X., Yuan N., Li C., Yang J., Cheng L., Lu Z., Hou H., Zhang B., Hu H., et al. T cell receptor β repertoires in patients with COVID-19 reveal disease severity signatures. Front. Immunol. 2023;14:1190844. doi: 10.3389/fimmu.2023.1190844.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1190844</ArticleId><ArticleId IdType="pmc">PMC10355153</ArticleId><ArticleId IdType="pubmed">37475855</ArticleId></ArticleIdList></Reference><Reference><Citation>Watkins T.S., Miles J.J. The human T-cell receptor repertoire in health and disease and potential for omics integration. Immunol. Cell Biol. 2021;99:135–145. doi: 10.1111/imcb.12377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imcb.12377</ArticleId><ArticleId IdType="pubmed">32677130</ArticleId></ArticleIdList></Reference><Reference><Citation>Musvosvi M., Huang H., Wang C., Xia Q., Rozot V., Krishnan A., Acs P., Cheruku A., Obermoser G., Leslie A., et al. T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection. Nat. Med. 2023;29:258–269. doi: 10.1038/s41591-022-02110-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02110-9</ArticleId><ArticleId IdType="pmc">PMC9873565</ArticleId><ArticleId IdType="pubmed">36604540</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamga L., Gil A., Song I., Brody R., Ghersi D., Aslan N., Stern L.J., Selin L.K., Luzuriaga K. CDR3α drives selection of the immunodominant Epstein Barr virus (EBV) BRLF1-specific CD8 T cell receptor repertoire in primary infection. PLoS Pathog. 2019;15:e1008122. doi: 10.1371/journal.ppat.1008122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008122</ArticleId><ArticleId IdType="pmc">PMC6901265</ArticleId><ArticleId IdType="pubmed">31765434</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Yang X., Ko A., Sun X., Gao M., Zhang Y., Shi A., Mariuzza R.A., Weng N. Sequence and Structural Analyses Reveal Distinct and Highly Diverse Human CD8+ TCR Repertoires to Immunodominant Viral Antigens. Cell Rep. 2017;19:569–583. doi: 10.1016/j.celrep.2017.03.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.03.072</ArticleId><ArticleId IdType="pmc">PMC5472051</ArticleId><ArticleId IdType="pubmed">28423320</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.-M., Feng P., Wu T.-H., Alachkar H., Lee K.-Y., Chang W.-C. Profiling of T Cell Repertoire in SARS-CoV-2-Infected COVID-19 Patients Between Mild Disease and Pneumonia. J. Clin. Immunol. 2021;41:1131–1145. doi: 10.1007/s10875-021-01045-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01045-z</ArticleId><ArticleId IdType="pmc">PMC8096628</ArticleId><ArticleId IdType="pubmed">33950324</ArticleId></ArticleIdList></Reference><Reference><Citation>Salomé B., Horowitz A. Impaired CD4 T-cell Response to SARS-CoV-2: Rationale for PD-1 Blockade in Patients with Cancer and COVID-19? Cancer Discov. 2021;11:1877–1878. doi: 10.1158/2159-8290.CD-21-0613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-21-0613</ArticleId><ArticleId IdType="pubmed">34344757</ArticleId></ArticleIdList></Reference><Reference><Citation>Messaoudi I., Patiño J.A.G., Dyall R., LeMaoult J., Nikolich-Žugich J. Direct Link Between mhc Polymorphism, T Cell Avidity, and Diversity in Immune Defense. Science. 2002;298:1797–1800. doi: 10.1126/science.1076064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1076064</ArticleId><ArticleId IdType="pubmed">12459592</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorochov G., Neumann A.U., Kereveur A., Parizot C., Li T., Katlama C., Karmochkine M., Raguin G., Autran B., Debré P. Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nat. Med. 1998;4:215–221. doi: 10.1038/nm0298-215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0298-215</ArticleId><ArticleId IdType="pubmed">9461196</ArticleId></ArticleIdList></Reference><Reference><Citation>Manuel M., Tredan O., Bachelot T., Clapisson G., Courtier A., Parmentier G., Rabeony T., Grives A., Perez S., Mouret J.-F., et al. Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients. OncoImmunology. 2012;1:432–440. doi: 10.4161/onci.19545.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/onci.19545</ArticleId><ArticleId IdType="pmc">PMC3382902</ArticleId><ArticleId IdType="pubmed">22754761</ArticleId></ArticleIdList></Reference><Reference><Citation>Saurwein-Teissl M., Lung T.L., Marx F., Gschösser C., Asch E., Blasko I., Parson W., Böck G., Schönitzer D., Trannoy E., et al. Lack of Antibody Production Following Immunization in Old Age: Association with CD8+CD28− T Cell Clonal Expansions and an Imbalance in the Production of Th1 and Th2 Cytokines1. J. Immunol. 2002;168:5893–5899. doi: 10.4049/jimmunol.168.11.5893.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.168.11.5893</ArticleId><ArticleId IdType="pubmed">12023394</ArticleId></ArticleIdList></Reference><Reference><Citation>Miles J.J., Douek D.C., Price D.A. Bias in the αβ T-cell repertoire: Implications for disease pathogenesis and vaccination. Immunol. Cell Biol. 2011;89:375–387. doi: 10.1038/icb.2010.139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2010.139</ArticleId><ArticleId IdType="pubmed">21301479</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.J., Lee K.A.V., Lam S.Z., Moon K.S., Fang Z., Chen S. Machine learning identifies T cell receptor repertoire signatures associated with COVID-19 severity. Commun. Biol. 2023;6:76. doi: 10.1038/s42003-023-04447-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-023-04447-4</ArticleId><ArticleId IdType="pmc">PMC9853487</ArticleId><ArticleId IdType="pubmed">36670287</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Clinical Management of COVID-19: Interim Guidance. World Health Organization; Geneva, Switzerland: 2020.</Citation></Reference><Reference><Citation>Sharafi F., Jafarzadeh Esfehani R., Moodi Ghalibaf A., Jarahi L., Shamshirian A., Mozdourian M. Leukopenia and leukocytosis as strong predictors of COVID-19 severity: A cross-sectional study of the hematologic abnormalities and COVID-19 severity in hospitalized patients. Health Sci. Rep. 2023;6:e1574. doi: 10.1002/hsr2.1574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hsr2.1574</ArticleId><ArticleId IdType="pmc">PMC10533955</ArticleId><ArticleId IdType="pubmed">37779668</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballabio D., Consonni V. Classification tools in chemistry. Part 1: Linear models. PLS-DA. Anal. Methods. 2013;5:3790. doi: 10.1039/c3ay40582f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c3ay40582f</ArticleId></ArticleIdList></Reference><Reference><Citation>Bro R., Smilde A.K. Principal component analysis. Anal. Methods. 2014;6:2812–2831. doi: 10.1039/C3AY41907J.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C3AY41907J</ArticleId></ArticleIdList></Reference><Reference><Citation>Buscema M. Back Propagation Neural Networks. Subst. Use Misuse. 1998;33:233–270. doi: 10.3109/10826089809115863.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10826089809115863</ArticleId><ArticleId IdType="pubmed">9516725</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennard R.W., Stone L.A. Computer Aided Design of Experiments. Technometrics. 1969;11:137–148. doi: 10.1080/00401706.1969.10490666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00401706.1969.10490666</ArticleId></ArticleIdList></Reference><Reference><Citation>Laydon D.J., Bangham C.R.M., Asquith B. Estimating T-cell repertoire diversity: Limitations of classical estimators and a new approach. Philos. Trans. R. Soc. B Biol. Sci. 2015;370:20140291. doi: 10.1098/rstb.2014.0291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2014.0291</ArticleId><ArticleId IdType="pmc">PMC4528489</ArticleId><ArticleId IdType="pubmed">26150657</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss P.A., Moots R.J., Rosenberg W.M., Rowland-Jones S.J., Bodmer H.C., McMichael A.J., Bell J.I. Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc. Natl. Acad. Sci. USA. 1991;88:8987–8990. doi: 10.1073/pnas.88.20.8987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.88.20.8987</ArticleId><ArticleId IdType="pmc">PMC52636</ArticleId><ArticleId IdType="pubmed">1833769</ArticleId></ArticleIdList></Reference><Reference><Citation>Argaet V.P., Schmidt C.W., Burrows S.R., Silins S.L., Kurilla M.G., Doolan D.L., Suhrbier A., Moss D.J., Kieff E., Sculley T.B., et al. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. J. Exp. Med. 1994;180:2335–2340. doi: 10.1084/jem.180.6.2335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.180.6.2335</ArticleId><ArticleId IdType="pmc">PMC2191762</ArticleId><ArticleId IdType="pubmed">7964506</ArticleId></ArticleIdList></Reference><Reference><Citation>Cibotti R., Cabaniols J.P., Pannetier C., Delarbre C., Vergnon I., Kanellopoulos J.M., Kourilsky P. Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice. J. Exp. Med. 1994;180:861–872. doi: 10.1084/jem.180.3.861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.180.3.861</ArticleId><ArticleId IdType="pmc">PMC2191659</ArticleId><ArticleId IdType="pubmed">8064237</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourcier K.D., Lim D.G., Ding Y.H., Smith K.J., Wucherpfennig K., Hafler D.A. Conserved CDR3 regions in T-cell receptor (TCR) CD8+ T cells that recognize the Tax11-19/HLA-A*0201 complex in a subject infected with human T-cell leukemia virus type 1: Relationship of T-cell fine specificity and major histocompatibility complex/peptide/TCR crystal structure. J. Virol. 2001;75:9836–9843. doi: 10.1128/JVI.75.20.9836-9843.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.20.9836-9843.2001</ArticleId><ArticleId IdType="pmc">PMC114556</ArticleId><ArticleId IdType="pubmed">11559817</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasprowicz V., Isa A., Jeffery K., Broliden K., Tolfvenstam T., Klenerman P., Bowness P. A highly restricted T-cell receptor dominates the CD8+ T-cell response to parvovirus B19 infection in HLA-A*2402-positive individuals. J. Virol. 2006;80:6697–6701. doi: 10.1128/JVI.02388-05.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02388-05</ArticleId><ArticleId IdType="pmc">PMC1488968</ArticleId><ArticleId IdType="pubmed">16775358</ArticleId></ArticleIdList></Reference><Reference><Citation>Godthelp B.C., van Tol M.J., Vossen J.M., van den Elsen P.J. Longitudinal analysis of T cells responding to tetanus toxoid in healthy subjects as well as in pediatric patients after bone marrow transplantation: The identification of identical TCR-CDR3 regions in time suggests long-term stability of at least part of the antigen-specific TCR repertoire. Int. Immunol. 2001;13:507–518. doi: 10.1093/intimm/13.4.507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/13.4.507</ArticleId><ArticleId IdType="pubmed">11282990</ArticleId></ArticleIdList></Reference><Reference><Citation>Sing G.K., Li D., Chen X., Macnaughton T., Lichanska A.M., Butterworth L., Ladhams A., Cooksley G. A molecular comparison of T lymphocyte populations infiltrating the liver and circulating in the blood of patients with chronic hepatitis B: Evidence for antigen-driven selection of a public complementarity-determining region 3 (CDR3) motif. Hepatology. 2001;33:1288–1298. doi: 10.1053/jhep.2001.24026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jhep.2001.24026</ArticleId><ArticleId IdType="pubmed">11343258</ArticleId></ArticleIdList></Reference><Reference><Citation>Umemura T., Yoshizawa K., Ota M., Katsuyama Y., Inada H., Tanaka E., Kiyosawa K. Analysis of T cell repertoire in the liver of patients with chronic hepatitis C. Clin. Exp. Immunol. 2000;121:120–126. doi: 10.1046/j.1365-2249.2000.01274.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.2000.01274.x</ArticleId><ArticleId IdType="pmc">PMC1905677</ArticleId><ArticleId IdType="pubmed">10886248</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillespie G.M.A., Stewart-Jones G., Rengasamy J., Beattie T., Bwayo J.J., Plummer F.A., Kaul R., McMichael A.J., Easterbrook P., Dong T., et al. Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection. J. Immunol. 2006;177:3893–3902. doi: 10.4049/jimmunol.177.6.3893.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.177.6.3893</ArticleId><ArticleId IdType="pubmed">16951352</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X.G., Lichterfeld M., Chetty S., Williams K.L., Mui S.K., Miura T., Frahm N., Feeney M.E., Tang Y., Pereyra F., et al. Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes. J. Virol. 2007;81:1619–1631. doi: 10.1128/JVI.01580-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01580-06</ArticleId><ArticleId IdType="pmc">PMC1797559</ArticleId><ArticleId IdType="pubmed">17121793</ArticleId></ArticleIdList></Reference><Reference><Citation>Simons B.C., Vancompernolle S.E., Smith R.M., Wei J., Barnett L., Lorey S.L., Meyer-Olson D., Kalams S.A. Despite biased TRBV gene usage against a dominant HLA B57-restricted epitope, TCR diversity can provide recognition of circulating epitope variants. J. Immunol. 2008;181:5137–5146. doi: 10.4049/jimmunol.181.7.5137.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.181.7.5137</ArticleId><ArticleId IdType="pubmed">18802118</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong L., Li P., Oenema T., McClurkan C.L., Koelle D.M. Public TCR Use by Herpes Simplex Virus-2–Specific Human CD8 CTLs. J. Immunol. 2010;184:3063–3071. doi: 10.4049/jimmunol.0903622.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0903622</ArticleId><ArticleId IdType="pmc">PMC2863070</ArticleId><ArticleId IdType="pubmed">20139278</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamo S., Michler J., Zurbuchen Y., Cervia C., Taeschler P., Raeber M.E., Baghai Sain S., Nilsson J., Moor A.E., Boyman O. Signature of long-lived memory CD8+ T cells in acute SARS-CoV-2 infection. Nature. 2022;602:148–155. doi: 10.1038/s41586-021-04280-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04280-x</ArticleId><ArticleId IdType="pmc">PMC8810382</ArticleId><ArticleId IdType="pubmed">34875673</ArticleId></ArticleIdList></Reference><Reference><Citation>Snyder T.M., Gittelman R.M., Klinger M., May D.H., Osborne E.J., Taniguchi R., Zahid H.J., Kaplan I.M., Dines J.N., Noakes M.T., et al. Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels. medRxiv. 2020 doi: 10.1101/2020.07.31.20165647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.31.20165647</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo L., Liang W., Pang J., Xu G., Chen Y., Guo X., Wang X., Zhao Y., Lai Y., Liu Y., et al. Dynamics of TCR repertoire and T cell function in COVID-19 convalescent individuals. Cell Discov. 2021;7:89. doi: 10.1038/s41421-021-00321-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00321-x</ArticleId><ArticleId IdType="pmc">PMC8476510</ArticleId><ArticleId IdType="pubmed">34580278</ArticleId></ArticleIdList></Reference><Reference><Citation>Gittelman R.M., Lavezzo E., Snyder T.M., Zahid H.J., Carty C.L., Elyanow R., Dalai S., Kirsch I., Baldo L., Manuto L., et al. Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection. JCI Insight. 2022;7:e151849. doi: 10.1172/jci.insight.151849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.151849</ArticleId><ArticleId IdType="pmc">PMC9220833</ArticleId><ArticleId IdType="pubmed">35439174</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilich T., Nelde A., Heitmann J.S., Maringer Y., Roerden M., Bauer J., Rieth J., Wacker M., Peter A., Hörber S., et al. T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals. Sci. Transl. Med. 2021;13:eabf7517. doi: 10.1126/scitranslmed.abf7517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf7517</ArticleId><ArticleId IdType="pmc">PMC8128286</ArticleId><ArticleId IdType="pubmed">33723016</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G., Zangrillo A., Zanella A., Antonelli M., Cabrini L., Castelli A., Cereda D., Coluccello A., Foti G., Fumagalli R., et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574. doi: 10.1001/jama.2020.5394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.5394</ArticleId><ArticleId IdType="pmc">PMC7136855</ArticleId><ArticleId IdType="pubmed">32250385</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez L., Beckford J., Alachkar H. Deciphering the TCR Repertoire to Solve the COVID-19 Mystery. Trends Pharmacol. Sci. 2020;41:518–530. doi: 10.1016/j.tips.2020.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2020.06.001</ArticleId><ArticleId IdType="pmc">PMC7305739</ArticleId><ArticleId IdType="pubmed">32576386</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q., Yang K., Wang W., Jiang L., Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846–848. doi: 10.1007/s00134-020-05991-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05991-x</ArticleId><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil A., Yassai M.B., Naumov Y.N., Selin L.K. Narrowing of human influenza A virus-specific T cell receptor α and β repertoires with increasing age. J. Virol. 2015;89:4102–4116. doi: 10.1128/JVI.03020-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03020-14</ArticleId><ArticleId IdType="pmc">PMC4442365</ArticleId><ArticleId IdType="pubmed">25609818</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T.H.O., Sant S., Bird N.L., Grant E.J., Clemens E.B., Koutsakos M., Valkenburg S.A., Gras S., Lappas M., Jaworowski A., et al. Perturbed CD8+ T cell immunity across universal influenza epitopes in the elderly. J. Leukoc. Biol. 2018;103:321–339. doi: 10.1189/jlb.5MA0517-207R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.5MA0517-207R</ArticleId><ArticleId IdType="pubmed">28928269</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan S., Kode V., Bhojak K., Karunakaran C., Lee K., Manoharan M., Ramesh A., Hv S., Srivastava A., Sathian R., et al. Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals. Sci. Rep. 2021;11:13164. doi: 10.1038/s41598-021-92521-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92521-4</ArticleId><ArticleId IdType="pmc">PMC8222233</ArticleId><ArticleId IdType="pubmed">34162945</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley P.R., Lee C.H., Pereira Pinho M., Ottakandathil Babu R., Woo J., Antanaviciute A., Simmons A., Ogg G., Koohy H. HLA-dependent variation in SARS-CoV-2 CD8+ T cell cross-reactivity with human coronaviruses. Immunology. 2022;166:78–103. doi: 10.1111/imm.13451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13451</ArticleId><ArticleId IdType="pmc">PMC9111820</ArticleId><ArticleId IdType="pubmed">35143694</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.C.S., Owen C.J., Tham C.Y.L., Bertoletti A., van Dorp L., Balloux F. Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses. Infect. Genet. Evol. 2021;95:105075. doi: 10.1016/j.meegid.2021.105075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2021.105075</ArticleId><ArticleId IdType="pmc">PMC8428999</ArticleId><ArticleId IdType="pubmed">34509646</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B., Tian J., Zhang Q., Xie Y., Wang K., Qiu S., Lu K., Liu Y. Comparing the Nucleocapsid Proteins of Human Coronaviruses: Structure, Immunoregulation, Vaccine, and Targeted Drug. Front. Mol. Biosci. 2022;9:761173. doi: 10.3389/fmolb.2022.761173.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2022.761173</ArticleId><ArticleId IdType="pmc">PMC9099148</ArticleId><ArticleId IdType="pubmed">35573742</ArticleId></ArticleIdList></Reference><Reference><Citation>Grifoni A., Weiskopf D., Ramirez S.I., Mateus J., Dan J.M., Moderbacher C.R., Rawlings S.A., Sutherland A., Premkumar L., Jadi R.S., et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181:1489–1501.e15. doi: 10.1016/j.cell.2020.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.015</ArticleId><ArticleId IdType="pmc">PMC7237901</ArticleId><ArticleId IdType="pubmed">32473127</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf D., Schmitz K.S., Raadsen M.P., Grifoni A., Okba N.M.A., Endeman H., van den Akker J.P.C., Molenkamp R., Koopmans M.P.G., van Gorp E.C.M., et al. Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome. Sci. Immunol. 2020;5:eabd2071. doi: 10.1126/sciimmunol.abd2071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd2071</ArticleId><ArticleId IdType="pmc">PMC7319493</ArticleId><ArticleId IdType="pubmed">32591408</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bert N., Tan A.T., Kunasegaran K., Tham C.Y.L., Hafezi M., Chia A., Chng M.H.Y., Lin M., Tan N., Linster M., et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020;584:457–462. doi: 10.1038/s41586-020-2550-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2550-z</ArticleId><ArticleId IdType="pubmed">32668444</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng M.H., Zhang S., Porritt R.A., Noval Rivas M., Paschold L., Willscher E., Binder M., Arditi M., Bahar I. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proc. Natl. Acad. Sci. USA. 2020;117:25254–25262. doi: 10.1073/pnas.2010722117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2010722117</ArticleId><ArticleId IdType="pmc">PMC7568239</ArticleId><ArticleId IdType="pubmed">32989130</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe M., Zuo J. Immune responses to Epstein-Barr virus: Molecular interactions in the virus evasion of CD8+ T cell immunity. Microbes Infect. 2010;12:173–181. doi: 10.1016/j.micinf.2009.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2009.12.001</ArticleId><ArticleId IdType="pmc">PMC2832755</ArticleId><ArticleId IdType="pubmed">20004735</ArticleId></ArticleIdList></Reference><Reference><Citation>Powers C., DeFilippis V., Malouli D., Früh K. Cytomegalovirus immune evasion. Curr. Top. Microbiol. Immunol. 2008;325:333–359. doi: 10.1007/978-3-540-77349-8_19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-540-77349-8_19</ArticleId><ArticleId IdType="pubmed">18637515</ArticleId></ArticleIdList></Reference><Reference><Citation>Beverley P.C.L., Grubeck-Loebenstein B. Is immune senescence reversible? Vaccine. 2000;18:1721–1724. doi: 10.1016/S0264-410X(99)00514-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(99)00514-9</ArticleId><ArticleId IdType="pubmed">10689156</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum P.D., Young J.J., Schmidt D., Zhang Q., Hoh R., Busch M., Martin J., Deeks S., McCune J.M. Blood T-cell receptor diversity decreases during the course of HIV infection, but the potential for a diverse repertoire persists. Blood. 2012;119:3469–3477. doi: 10.1182/blood-2011-11-395384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-11-395384</ArticleId><ArticleId IdType="pmc">PMC3325037</ArticleId><ArticleId IdType="pubmed">22371879</ArticleId></ArticleIdList></Reference><Reference><Citation>Klarenbeek P.L., Tak P.P., van Schaik B.D.C., Zwinderman A.H., Jakobs M.E., Zhang Z., van Kampen A.H.C., van Lier R.A.W., Baas F., de Vries N. Human T-cell memory consists mainly of unexpanded clones. Immunol. Lett. 2010;133:42–48. doi: 10.1016/j.imlet.2010.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2010.06.011</ArticleId><ArticleId IdType="pubmed">20621124</ArticleId></ArticleIdList></Reference><Reference><Citation>Miconnet I., Marrau A., Farina A., Taffé P., Vigano S., Harari A., Pantaleo G. Large TCR Diversity of Virus-Specific CD8 T Cells Provides the Mechanistic Basis for Massive TCR Renewal after Antigen Exposure. J. Immunol. 2011;186:7039–7049. doi: 10.4049/jimmunol.1003309.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1003309</ArticleId><ArticleId IdType="pubmed">21555537</ArticleId></ArticleIdList></Reference><Reference><Citation>Dash P., Fiore-Gartland A.J., Hertz T., Wang G.C., Sharma S., Souquette A., Crawford J.C., Clemens E.B., Nguyen T.H.O., Kedzierska K., et al. Quantifiable predictive features define epitope-specific T cell receptor repertoires. Nature. 2017;547:89–93. doi: 10.1038/nature22383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22383</ArticleId><ArticleId IdType="pmc">PMC5616171</ArticleId><ArticleId IdType="pubmed">28636592</ArticleId></ArticleIdList></Reference><Reference><Citation>Price D.A., Brenchley J.M., Ruff L.E., Betts M.R., Hill B.J., Roederer M., Koup R.A., Migueles S.A., Gostick E., Wooldridge L., et al. Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J. Exp. Med. 2005;202:1349–1361. doi: 10.1084/jem.20051357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20051357</ArticleId><ArticleId IdType="pmc">PMC2212993</ArticleId><ArticleId IdType="pubmed">16287711</ArticleId></ArticleIdList></Reference><Reference><Citation>Zehn D., Lee S.Y., Bevan M.J. Complete but curtailed T-cell response to very low-affinity antigen. Nature. 2009;458:211–214. doi: 10.1038/nature07657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07657</ArticleId><ArticleId IdType="pmc">PMC2735344</ArticleId><ArticleId IdType="pubmed">19182777</ArticleId></ArticleIdList></Reference><Reference><Citation>Pogorelyy M.V., Fedorova A.D., McLaren J.E., Ladell K., Bagaev D.V., Eliseev A.V., Mikelov A.I., Koneva A.E., Zvyagin I.V., Price D.A., et al. Exploring the pre-immune landscape of antigen-specific T cells. Genome Med. 2018;10:68. doi: 10.1186/s13073-018-0577-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-018-0577-7</ArticleId><ArticleId IdType="pmc">PMC6109350</ArticleId><ArticleId IdType="pubmed">30144804</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman W., Hageman L., Khmelevskaya A., Amsen D., Falkenburg J.H.F., Jedema I. Public T-Cell Receptors (TCRs) Revisited by Analysis of the Magnitude of Identical and Highly-Similar TCRs in Virus-Specific T-Cell Repertoires of Healthy Individuals. Front. Immunol. 2022;13:851868. doi: 10.3389/fimmu.2022.851868.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.851868</ArticleId><ArticleId IdType="pmc">PMC8987591</ArticleId><ArticleId IdType="pubmed">35401538</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Nguyen P., Ma J., Wu T., Jones L.L., Pei D., Cheng C., Geiger T.L. Preferential Use of Public TCR during Autoimmune Encephalomyelitis. J. Immunol. 2016;196:4905–4914. doi: 10.4049/jimmunol.1501029.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1501029</ArticleId><ArticleId IdType="pmc">PMC4902001</ArticleId><ArticleId IdType="pubmed">27183575</ArticleId></ArticleIdList></Reference><Reference><Citation>Shomuradova A.S., Vagida M.S., Sheetikov S.A., Zornikova K.V., Kiryukhin D., Titov A., Peshkova I.O., Khmelevskaya A., Dianov D.V., Malasheva M., et al. SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T-cell receptors. Immunity. 2020;53:1245–1257. doi: 10.1016/j.immuni.2020.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.11.004</ArticleId><ArticleId IdType="pmc">PMC7664363</ArticleId><ArticleId IdType="pubmed">33326767</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu W., He M., Wang X., Sun Q., Kuang M. Specific CD8+ TCR Repertoire Recognizing Conserved Antigens of SARS-CoV-2 in Unexposed Population: A Prerequisite for Broad-Spectrum CD8+ T Cell Immunity. Vaccines. 2021;9:1093. doi: 10.3390/vaccines9101093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9101093</ArticleId><ArticleId IdType="pmc">PMC8541101</ArticleId><ArticleId IdType="pubmed">34696201</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T.H.O., Cohen C.A., Rowntree L.C., Bull M.B., Hachim A., Kedzierska K., Valkenburg S.A. T Cells Targeting SARS-CoV-2: By Infection, Vaccination, and Against Future Variants. Front. Med. 2021;8:793102. doi: 10.3389/fmed.2021.793102.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.793102</ArticleId><ArticleId IdType="pmc">PMC8739267</ArticleId><ArticleId IdType="pubmed">35004764</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y., Felce S.L., Dong D., Penkava F., Mentzer A.J., Yao X., Liu G., Yin Z., Chen J.-L., Lu Y., et al. An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease. Nat. Immunol. 2022;23:50–61. doi: 10.1038/s41590-021-01084-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01084-z</ArticleId><ArticleId IdType="pmc">PMC8709787</ArticleId><ArticleId IdType="pubmed">34853448</ArticleId></ArticleIdList></Reference><Reference><Citation>Lineburg K.E., Grant E.J., Swaminathan S., Chatzileontiadou D.S.M., Szeto C., Sloane H., Panikkar A., Raju J., Crooks P., Rehan S., et al. CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses. Immunity. 2021;54:1055–1065.e5. doi: 10.1016/j.immuni.2021.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.04.006</ArticleId><ArticleId IdType="pmc">PMC8043652</ArticleId><ArticleId IdType="pubmed">33945786</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateus J., Grifoni A., Tarke A., Sidney J., Ramirez S.I., Dan J.M., Burger Z.C., Rawlings S.A., Smith D.M., Phillips E., et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science. 2020;370:89–94. doi: 10.1126/science.abd3871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3871</ArticleId><ArticleId IdType="pmc">PMC7574914</ArticleId><ArticleId IdType="pubmed">32753554</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng K.W., Faulkner N., Cornish G.H., Rosa A., Harvey R., Hussain S., Ulferts R., Earl C., Wrobel A.G., Benton D.J., et al. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science. 2020;370:1339–1343. doi: 10.1126/science.abe1107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe1107</ArticleId><ArticleId IdType="pmc">PMC7857411</ArticleId><ArticleId IdType="pubmed">33159009</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber S., Kehl V., Erber J., Wagner K.I., Jetzlsperger A.-M., Burrell T., Schober K., Schommers P., Augustin M., Crowell C.S., et al. CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients. PLoS ONE. 2022;17:e0268530. doi: 10.1371/journal.pone.0268530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0268530</ArticleId><ArticleId IdType="pmc">PMC9132318</ArticleId><ArticleId IdType="pubmed">35613127</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>